Several studies have demonstrated PGK1 can enhance the proliferation and migration ability of tumors by activating CXCR4 in gastric cancer and neuroblastoma [44–46], but PGK1/CXCR4/ERK molecules and related signaling pathways have not been investigated in RCC in previous reports. This evidence concerns the gene CXCR4 and renal cell carcinoma.